Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mi-Sook Kim

Showing results (211-220 of 217) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 217 results.
International Journal of Radiation Oncology, Biology, Physics|August 19, 2023
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice GuidelinesSun Hyun Bae, Seok-Joo Chun, Joo-Hyun Chung, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2010
Discovery and optimization of pyrazoline compounds as B-Raf inhibitorsMatthew O Duffey, Ruth Adams, Christopher Blackburn, et al.
Journal of Liver Cancer|September 3, 2025
Impact of the 2024 medical-policy conflict on hepatocellular carcinoma management in KoreaSoon Sun Kim, Hyun Yang, Jieun Kwon, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 7, 2008
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategyTadeusz Majewski, Sangkyou Lee, Joon Jeong, et al.
Science (New York, N.Y.)|June 2, 2022
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategyStanley C Xie, Riley D Metcalfe, Elyse Dunn, et al.
Journal of Medicinal Chemistry|February 24, 2011
Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitorsAlexandra E Gould, Ruth Adams, Sharmila Adhikari, et al.
Journal of Medicinal Chemistry|February 26, 2021
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven P Langston, Stephen Grossman, Dylan England, et al.
Pageof 22

Showing results (211-220 of 217) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 217 results.
International Journal of Radiation Oncology, Biology, Physics|August 19, 2023
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice GuidelinesSun Hyun Bae, Seok-Joo Chun, Joo-Hyun Chung, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2010
Discovery and optimization of pyrazoline compounds as B-Raf inhibitorsMatthew O Duffey, Ruth Adams, Christopher Blackburn, et al.
Journal of Liver Cancer|September 3, 2025
Impact of the 2024 medical-policy conflict on hepatocellular carcinoma management in KoreaSoon Sun Kim, Hyun Yang, Jieun Kwon, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 7, 2008
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategyTadeusz Majewski, Sangkyou Lee, Joon Jeong, et al.
Science (New York, N.Y.)|June 2, 2022
Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategyStanley C Xie, Riley D Metcalfe, Elyse Dunn, et al.
Journal of Medicinal Chemistry|February 24, 2011
Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitorsAlexandra E Gould, Ruth Adams, Sharmila Adhikari, et al.
Journal of Medicinal Chemistry|February 26, 2021
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven P Langston, Stephen Grossman, Dylan England, et al.
Pageof 22